BioAge stock rallies 29% following upsized $198M IPO
WEB2 days ago · Shares of BioAge (BIOA) recently sold for $23.30, up 29% from its offering price, at around 12:20 p.m. ET. BioAge (BIOA) priced 11M shares at $18 per share. Underwriters were granted a 30-day ...
BioAge Labs Announces Pricing of Upsized Initial Public Offering
WEB2 days ago · Advertisement. RICHMOND, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product ...
BioAge Labs IPO: stock price today in high-profile Nasdaq debut
WEB2 days ago · BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq. The California-based biotech priced its shares at $18. Its lead product, a weight ...
BioAge valued at $758 million in debut as investors bet on ... - Yahoo
WEB2 days ago · BioAge sold 11 million shares, 46.7% more than originally planned, to raise $198 million after twice upsizing its IPO. The offer was priced at the midpoint of the marketed range of $17 and $19.
BioAge posts double-digit percentage jump after IPO; natural-gas ...
WEB2 days ago · BioAge (BIOA) shares opened at $22.50 and recently changed hands at $21.96, above their $18 IPO price. BKV's stock (BKV) opened at $18.55 a share, above its own $18 IPO price, and was trading at ...
Weight-loss drug developer BioAge raises $198 million in U.S. IPO
WEB2 days ago · BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the range at $18 per share, the weight-loss drug developer said on Wednesday. The ...
BioAge posts double-digit percentage gain after IPO; natural-gas ...
WEB2 days ago · Obesity-drug developer BioAge Labs Inc. gained nearly 30% after its initial public offering on Thursday, while natural-gas producer BKV Inc.'s rose about 3% over its $18 IPO price. BioAge (BIOA ...
BioAge Labs stock soars in weight loss drug maker's IPO - Quartz
WEB2 days ago · BioAge initially said that it planned to only offer 7.5 million shares between $17 to $19 each. The company’s stock initially surged 24% to over $22 Thursday. It is trading on the Nasdaq Global ...
BioAge Labs, A New Obesity Treatment Name, Rockets On …
WEB2 days ago · The Richmond, Calif.-based company plans to raise $189 million by offering 10.5 million shares at a range of $17 to $19 per share, according to Renaissance Capital. But in midday trades, BioAge ...
Obesity drug developer BioAge raises $198m in IPO
WEB2 days ago · BioAge Labs has completed its upsized initial public offering (IPO), raising $198 million after increasing the number of shares on offer by 40%. The expansion of the listing reflects the massive ...
- Some results have been removed